Dr. Luigi Buonaguro
Director
Innovative Immunological Models Unit, National Cancer Institute - IRCCS “Pascaleâ€
ITALY
Biography
Dr. Luigi Buonaguro received his medical degree in 1988 from the Univ. of Naples – Italy “Federico IIâ€; in 1992 he received his Microbiology and Virology specialty degree from the same University. After his PostDoctoral training at the Lab. of Tumor Cell Biology, Natl. Cancer Inst., Natl. Institutes of Health, Bethesda MD, USA (Director, Robert C. Gallo), he joined the Lab. of Viral Oncology at the National Cancer Institute “Fond. Pascaleâ€, Naples – Italy, where he currently is an Senior Staff Scientist of the Mol Biol and Viral Oncogenesis Unit and Head of Experimental Immunotherapy Lab. From 2005 he has an appointment as Adjunct Associate Professor, Univ. of Maryland School of Medicine, Infectious Diseases Division at Institute of Human Virology, Baltimore MD – USA (Director, Robert C. Gallo). Dr. Buonaguro is Member of the Following Scientific Societies: Italian Society for Virology (Società Italiana di Virologia – SIV); Italian Society for Medical Virology (Società Italiana di Virologia Medica – SIVIM); American Society for Microbiology (ASM); American Association for Cancer Research (AACR); CIMT. He is member of the CVC Trials Network of the Cancer Research Institute. He is currently involved in development of cancer vaccine approaches targeting hepatocellular carcinoma.
Research Interest
Viral Oncology, Vaccines, Immunology, cancer, hiv